377 related articles for article (PubMed ID: 33717763)
1. Atypical Hemolytic Uremic Syndrome: Cancer-Induced or Chemotherapy-Induced?
Sethi A; Moses R
Cureus; 2021 Feb; 13(2):e13260. PubMed ID: 33717763
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Atypical Hemolytic-Uremic Syndrome in the Era of Eculizumab.
Ebrahem R; Kadhem S; Truong Q
Cureus; 2017 Mar; 9(3):e1111. PubMed ID: 28439485
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological and clinical profile of ravulizumab 100 mg/mL formulation for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
Ariceta G
Expert Rev Clin Pharmacol; 2023 May; 16(5):401-410. PubMed ID: 37128905
[TBL] [Abstract][Full Text] [Related]
4. Atypical hemolytic uremic syndrome: Review of clinical presentation, diagnosis and management.
Sridharan M; Go RS; Willrich MAV
J Immunol Methods; 2018 Oct; 461():15-22. PubMed ID: 30031798
[TBL] [Abstract][Full Text] [Related]
5. Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment.
Raina R; Krishnappa V; Blaha T; Kann T; Hein W; Burke L; Bagga A
Ther Apher Dial; 2019 Feb; 23(1):4-21. PubMed ID: 30294946
[TBL] [Abstract][Full Text] [Related]
6. Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome.
Lee H; Kang E; Kang HG; Kim YH; Kim JS; Kim HJ; Moon KC; Ban TH; Oh SW; Jo SK; Cho H; Choi BS; Hong J; Cheong HI; Oh D
Korean J Intern Med; 2020 Jan; 35(1):25-40. PubMed ID: 31935318
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome.
Shen YM
Thromb J; 2016; 14(Suppl 1):19. PubMed ID: 27766045
[TBL] [Abstract][Full Text] [Related]
8. Atypical Hemolytic Uremic Syndrome Secondary to Lupus Nephritis, Responsive to Eculizumab.
Raufi AG; Scott S; Darwish O; Harley K; Kahlon K; Desai S; Lu Y; Tran MH
Hematol Rep; 2016 Sep; 8(3):6625. PubMed ID: 27781079
[TBL] [Abstract][Full Text] [Related]
9. Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial.
Fakhouri F; Hourmant M; Campistol JM; Cataland SR; Espinosa M; Gaber AO; Menne J; Minetti EE; Provôt F; Rondeau E; Ruggenenti P; Weekers LE; Ogawa M; Bedrosian CL; Legendre CM
Am J Kidney Dis; 2016 Jul; 68(1):84-93. PubMed ID: 27012908
[TBL] [Abstract][Full Text] [Related]
10. Atypical Hemolytic Uremic Syndrome Associated With Clostridium Difficile Infection.
Khurshid Q; Mahmoud A; Shahid M; Mohamed A; Shahbaz A
Cureus; 2020 Jul; 12(7):e9005. PubMed ID: 32775085
[TBL] [Abstract][Full Text] [Related]
11. Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
Yuan X; Gavriilaki E; Thanassi JA; Yang G; Baines AC; Podos SD; Huang Y; Huang M; Brodsky RA
Haematologica; 2017 Mar; 102(3):466-475. PubMed ID: 27810992
[TBL] [Abstract][Full Text] [Related]
12. Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab.
Andries G; Karass M; Yandrapalli S; Linder K; Liu D; Nelson J; Pawar R; Chugh S
Exp Hematol Oncol; 2017; 6():4. PubMed ID: 28101432
[TBL] [Abstract][Full Text] [Related]
13. Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
Ito S; Hidaka Y; Inoue N; Kaname S; Kato H; Matsumoto M; Miyakawa Y; Mizuno M; Okada H; Shimono A; Matsuda T; Maruyama S; Fujimura Y; Nangaku M; Kagami S
Clin Exp Nephrol; 2019 Jan; 23(1):112-121. PubMed ID: 30039480
[TBL] [Abstract][Full Text] [Related]
14. Atypical hemolytic uremic syndrome: a case report.
Basnayake BMDB; Wazil AWM; Nanayakkara N; Samarakoon SMDK; Senavirathne EMSK; Thangarajah BUEWDR; Karunasena N; Mahanama RMBSS
J Med Case Rep; 2020 Jan; 14(1):11. PubMed ID: 31928535
[TBL] [Abstract][Full Text] [Related]
15. Rare Presentation of Atypical Hemolytic Uremic Syndrome in an Adult.
Alhabhbeh A; Fatima Z; Thomas A; Cook C
Cureus; 2021 Sep; 13(9):e18184. PubMed ID: 34589371
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of Atypical Hemolytic Uremic Syndrome.
Yoshida Y; Kato H; Ikeda Y; Nangaku M
J Atheroscler Thromb; 2019 Feb; 26(2):99-110. PubMed ID: 30393246
[TBL] [Abstract][Full Text] [Related]
17. Complement activation in diseases presenting with thrombotic microangiopathy.
Meri S
Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
[TBL] [Abstract][Full Text] [Related]
18. Clinical guides for atypical hemolytic uremic syndrome in Japan.
Kato H; Nangaku M; Hataya H; Sawai T; Ashida A; Fujimaru R; Hidaka Y; Kaname S; Maruyama S; Yasuda T; Yoshida Y; Ito S; Hattori M; Miyakawa Y; Fujimura Y; Okada H; Kagami S;
Clin Exp Nephrol; 2016 Aug; 20(4):536-543. PubMed ID: 27422619
[TBL] [Abstract][Full Text] [Related]
19. An adult case of atypical hemolytic uremic syndrome presented with posterior reversible encephalopathy syndrome: Successful response to late-onset eculizumab treatment.
Medeni SS; Namdaroglu S; Cetintepe T; Ozlu C; Tasli F; Adibelli ZH; Bilgir O; Tatar E
Hematol Rep; 2018 Sep; 10(3):7553. PubMed ID: 30344987
[TBL] [Abstract][Full Text] [Related]
20. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.
Krishnappa V; Gupta M; Elrifai M; Moftakhar B; Ensley MJ; Vachharajani TJ; Sethi SK; Raina R
Ther Apher Dial; 2018 Apr; 22(2):178-188. PubMed ID: 29250893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
